- Current and future strategies for the treatment of chronic hepatitis C
-
Alshuwaykh O, Kwo PY
- KMID: 2514764
- Clin Mol Hepatol.
- 2021 Apr;27(2):246-256.
- doi: 10.3350/cmh.2020.0230
Chronic hepatitis C infection is a major cause of liver disease and hepatocellular carcinoma worldwide. While hepatitis C has been treated for decades with some success, the introduction of direct... -
- CITED
-
- Close
- SHARE
-
- Close
- The Therapeutic Approaches for Hepatitis C Virus: Protease Inhibitors and Polymerase Inhibitors
-
Kwo PY, Vinayek R
- KMID: 2284229
- Gut Liver.
- 2011 Dec;5(4):406-417.
The current standard of care for hepatitis C infection is peginterferon/ribavirin (PegIFN/RBV). We are entering the era where direct-acting antiviral agents (DAAs) will be added to PegIFN/RBV, leading to higher... -
- CITED
-
- Close
- SHARE
-
- Close
